My WebLink
|
Help
|
About
|
Sign Out
Home
Agenda - Council Work Session - 04/11/2023
Ramsey
>
Public
>
Agendas
>
Council Work Session
>
2023
>
Agenda - Council Work Session - 04/11/2023
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/13/2025 11:12:17 AM
Creation date
4/6/2023 3:55:03 PM
Metadata
Fields
Template:
Meetings
Meeting Document Type
Agenda
Meeting Type
Council Work Session
Document Date
04/11/2023
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
566
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 <br />280.1 (2) any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or <br />280.2 any salt of any of these drugs and approved by the food and drug administration for marketing <br />280.3 only as a suppository; <br />280.4 (3) any substance which contains any quantity of a derivative of barbituric acid, or any <br />280.5 salt of a derivative of barbituric acid, except those substances which are specifically listed <br />280.6 in other schedules; <br />280.7 (4) any drug product containing gamma hydroxybutyric acid, including its salts, isomers, <br />280.8 and salts of isomers, for which an application is approved under section 505 of the federal <br />280.9 Food, Drug, and Cosmetic Act; <br />280.10 (5) any of the following substances: <br />280.11 (i) chlorhexadol; <br />280.12 (ii) ketamine, its salts, isomers and salts of isomers; <br />280.13 (iii) lysergic acid; <br />280.14 (iv) lysergic acid amide; <br />280.15 (v) methyprylon; <br />280.16 (vi) sulfondnthylmethane; <br />280.17 (vii) sulfonenthylmethane; <br />280.18 (viii) sulfonmethane; <br />280.19 (ix) tiletamine and zolazepam and any salt thereof; <br />280.20 (x) embutramide; <br />280.21 (xi) Perampanel [2-(2-oxo-l-phenyl-5-pyridin-2-yl-1,2-Dihydropyridin-3-yl) <br />280.22 benzonitrile] . <br />280.23 (d) Nalorphine. <br />280.24 (e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, <br />280.25 any material, compound, mixture, or preparation containing any of the following narcotic <br />280.26 drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities <br />280.27 as follows: <br />280.28 (1) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams <br />280.29 per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium; <br />Article 8 Sec. 2. 280 <br />
The URL can be used to link to this page
Your browser does not support the video tag.